|
|
 |
|
Viewing report
|
|
 |
 |
Progenics Pharmaceuticals, Inc. - Strategy and SWOT Report
Datamonitor, Oct 2011, Pages: 41
Progenics Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Progenics Pharmaceuticals, Inc. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Progenics Pharmaceuticals, Inc. in the form of a SWOT analysis - An in-depth view of the business model of Progenics Pharmaceuticals, Inc. including a breakdown and examination of key business segments - Intelligence on Progenics Pharmaceuticals, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Progenics Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Progenics Pharmaceuticals (Progenics) is a biopharmaceutical company focusing on the development and commercialization of therapeutic products. The company operates in the US. It is headquartered in Tarrytown, New York and employed 159 people as of December 31, 2010. The company recorded revenues of $8 million during the financial year ended December 2010 (FY2010), a decrease of 83.8% compared with FY2009. The operating loss of the company was $69.9 million during FY2010, as compared to operating loss of $32.3 million in FY2009. The net loss was $69.7 million in FY2010, as compared to net loss of $30.6 million in FY2009.
Reasons to Purchase:
- Gain understanding of Progenics Pharmaceuticals, Inc. and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Progenics Pharmaceuticals, Inc. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Progenics Pharmaceuticals, Inc.’s business structure, strategy and prospects
|
 |
|
|